Steven Swanson | Senior Vice President, Research
Immunocellular Therapeutics

Steven Swanson, Senior Vice President, Research, Immunocellular Therapeutics


Day One @ 16:20

Novel personalized immune therapies for solid tumors

  •     Mobilizing the immune system through patient specific biomarkers
  •     Designing Ph III immunotherapy trials incorporating lessons from Ph II
  •     Manufacturing: why producing sufficient cells is a challenge and how to overcome this through optimized mixing, aeration, and perfusion

back to speakers